Clinical Trial

Association Between Triglyceride Glucose Index and Severity of Coronary Artery Disease

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 11, 2024 (before its estimated December 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
Coronary artery disease (CAD) is a chronic cardiovascular disease occurring due to atherosclerotic occlusion of the coronary arteries (1). Acute coronary syndrome (ACS) is the most severe type of Coronary artery disease including unstable angina(UA) , St -elevation myocardial infarction (STEMI) Non ST elevation mayocardial infarction (NSTEMI) (2). Despite the use of current guidline-recommended therapeutics including Percutaneous coronary intervention (PCI) or coronary Artery bypass Grafting (CABG) and optimal drug treatments some patients with ischemic heart disease (IHD) remain at high risk for recurrent Cardio vascular events(3). Triglyceride glucose index (TYG) has a good potential in predicting poor cardiovascular prognosis in patients with IHD (4).
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06495879
Lead Sponsor Sohag University
Conditions Coronary Artery Disease
Enrollment 100 participants
Start Date 2024-09-01
Primary Completion 2024-12-01 (estimated)
Study Completion 2025-01-01 (estimated)
Updated on ClinicalTrials.gov 2024-07-11